Meeting the Future Together

We bring a future-focused approach to therapies, improving the lives of patients and supporting providers through sustainable innovation of care.

Our commitment to care

Special Care

Fresh thinking, proven approaches to special care, including neonatology and critical care.

Our care approach

Rare Diseases

Bringing world-class resources to developing therapies for rare and ultra-rare disorders.

Our rare disease mission

Products

Committed to developing and commercializing products that meet the needs of providers and their patients.

Learn about our products

Our Work

See how our future-focused approach helps improve the lives of patients all over the world.

See our work in action

Innovating Care

Learn how our therapeutic focus brings tomorrow's outcomes closer to today.

Explore our innovative focus areas

Partners in Treatment

We work to build an ecosystem of care that begins in our labs, is powered by dedicated care teams, and shines through every day for patients.

Our partnership approach

News

15/10/2025

Chiesi Announces FDA Acceptance of New Drug Application for its Triple Combination Inhaler for the Maintenance Treatment of Asthma

09/10/2024

Chiesi USA Releases 2023 Sustainability Report and Highlights US Community Engagement Strategy Focus Areas

16/05/2024

Chiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic Society 2024 International Conference

15/04/2024

Chiesi USA Appoints Richard Smith as Vice President and Business Unit Leader, U.S. AIR

08/08/2023

Chiesi Group Mid-Year Financial Results Demonstrate Strong Growth for 2023

20/07/2023

Chiesi USA CEO Appointed to ASHP Foundation Board of Directors

12/06/2023

Chiesi USA Partners with Smith Anderson to Host 1L Excellence in Diversity Fellow this Summer